Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
Clinical trial NCT01549834 · COMPLETED
Trial details
- NCT number
- NCT01549834
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-10-01
- Enrollment
- 434
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.